Affiliate Talking Points: What You Can and Cannot Say

For research-oriented conversation only. Not medical advice. Read this before you talk to anyone about a Portal to Wellness compound.

The one rule: you never give a number. Not an amount, not a frequency, not a duration, not “what most people do”. If a conversation is heading toward how a person would use a compound, stop it and point to a licensed clinician.

The Second Rule: Some Compounds Are Off Limits Entirely

You may not promote the GLP-1 class. That means Retatrutide, Semaglutide, Cagrilintide and Orforglipron — every vial size, every format — and any kit or stack containing one of them. Do not name them, picture them, describe them, compare them, or link to their product pages.

This applies everywhere, not just to public posts. A DM counts. A group chat counts. A reply to someone who asked you first counts. If a conversation arrives at one of these compounds, the answer is “that’s not one I can talk about — the product page has everything on it,” and then move on.

You still earn on them. If a customer you referred buys one of these through your link or code, the commission is paid exactly as it would be on anything else, under the same lifetime attribution. Nothing about your earnings changes. What changes is that you are not the one putting them in front of people.

Why this one is absolute

These compounds are the subject of active litigation across the industry, and the legal argument being run does not turn on whether anyone made a health claim. It turns on the overall picture a storefront presents — what is sold, how it is described, and who is being spoken to. Affiliate copy is part of that picture, because an affiliate is marketing on our behalf and what you write is attributable to us.

Everything else in the catalogue is open to you under the rules on the rest of this page. BPC-157, TB-500, MOTS-c and the recovery and longevity range are where the research is strongest and where we would rather your attention was anyway.

This list can change. If a compound is added or removed you will be told directly — do not rely on a version of this page you saved or screenshotted.

The Core Message

“We supply these compounds for laboratory research and identification only. We publish what the peer-reviewed literature reports, we say plainly where human data does not exist, and we do not invent numbers.”

Most of the market makes up dosing charts. We do not. That difference is the most trust-building thing you can say, and it is why a serious customer stays with us.

Why We Do Not Publish Amounts, Schedules or Routes

1. These products are sold for research use only

They are not for human or animal consumption, ingestion, injection or treatment. Publishing a preparation or usage figure would contradict the basis on which they are sold — and regulators look past the label to the whole marketing context, including what affiliates say.

2. For most of these compounds there is no human figure to publish

Much of this literature is preclinical: cell models and animal studies. Where human trials exist they are usually small, and the compound involved is an approved pharmaceutical rather than a research-supply vial. Presenting any of it as a usage figure would be inventing certainty that does not exist.

How to Answer “How Much Should I Take?”

Say: “I genuinely can’t tell you that, and honestly nobody selling it should. What I can point you at is the published research on that compound in our Research Library, so you can read the primary sources yourself.”

Say: “If you want guidance for your own situation, that is a conversation for a licensed clinician who can actually see your history.”

Say: “What I can help with is the compound itself — what it is, what class it belongs to, and what stage the research is at.”

Never say: a specific amount, frequency, cycle length or duration for any product — even if you personally have a view, even if the customer pushes, even in a private message.

Never say: anything about how a product would be prepared or used. Preparation guidance is usage guidance.

Never say: that a compound treats, cures, prevents, reverses or improves any condition, and never describe what a customer will feel, notice or achieve.

Never say: anything about your own or another customer’s personal results.

What You Can Point To

The Research Library — published studies summarised by compound, with citations.
Compound class, receptor or pathway, and what stage the research is at.
Practical order questions: pricing, shipping, payment, stock.

Conversation Starters That Stay Clean

“That compound is still preclinical — the interesting work is in animal models rather than people. Want the citations?”

“We publish where the human data stops rather than papering over it. That is unusual in this market.”

If you are unsure, say less. There is no commission worth a warning letter. If a question feels like it is asking you to advise on personal use, it is — hand it to a clinician and move on.